Newly Published Trial Data for Melanoma
Focus on TIGIT Immunotherapy What Is Immunotherapy? Many people with healthy immune systems still develop cancer. Sometimes the immune system…
Melanoma Research
08/26/2025
Newly Published Trial Data for Melanoma
Focus on TIGIT Immunotherapy What Is Immunotherapy? Many people with healthy immune systems still develop cancer. Sometimes the immune system…
|
08/26/2025
RP1 + Nivolumab Rejection: Advocating for Patients and Trust in Clinical Trials
FDA Rejects Promising Melanoma Treatment On July 22, 2025, the Food and Drug Administration (FDA) rejected the approval of a…
|
08/11/2025
IO Biotech Announces Phase 3 Results for Cylembio® + KEYTRUDA® in Advanced Melanoma
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT) today announces topline results from the pivotal Phase…
|
|
07/18/2025
Understanding Tumor Genetics and Melanoma: A Recap of Our Latest Webinar
In the age of precision medicine, understanding the genetics of a tumor—not just a person’s inherited DNA—is playing a critical…
|
06/18/2025
Melanoma News and Highlights You Don’t Want to Miss
We know staying informed about melanoma research and treatments is important to you. That’s why we’ve put together some of…
|
06/05/2025
Nivolumab at Micro Doses Works Better than Chemotherapy Against Relapsed Cancer
In Mumbai, India, and other parts of the world, immunotherapy is not always available for every patient who needs it.…
|
06/05/2025
The Time of Day Pembrolizumab is Administered May Link to Patient Survival
Timing matters. A study presented at the annual meeting of the American Society of Clinical Oncology in Chicago suggests that…
|
06/05/2025
Three New Immunotherapy Agents Tested Against Melanoma in Phase 2 Clinical Trials
Several new agents designed to reactivate the immune system were tested in combination with FDA-approved immunotherapies, as reported in data…
|
06/05/2025
Genetic Test a Potential Alternative to Sentinel Lymph Node Biopsy
There may be a non-invasive option available for patients with head and neck melanoma who cannot easily receive a sentinel…
|
06/05/2025
New Therapy in Clinical Trial Returns Immunotherapeutic Activity to Resistant Melanoma
A group in Italy may have found a way to revive the response to immunotherapy in patients who have developed…
|
Recent Posts
Sep. 09, 2025
Caring Through Loss: A Conversation on Bereavement
Sep. 05, 2025
Advocating for Patients: Letter to the FDA on RP1 Treatment Access
Sep. 04, 2025
Hope on the Horizon: Clinical Trials & Progress in Ocular/Uveal Melanoma
Aug. 26, 2025
Back to AIM: Advocacy, Walks, and Fall Initiatives in Melanoma
Aug. 26, 2025